PHI with Cystic liver
How does this condition affect your private health insurance?
Zystenleber, or Polycystic Liver Disease (PLD), is a condition characterized by the presence of numerous cysts of varying sizes throughout the liver. It is often inherited, commonly occurring alongside Autosomal Dominant Polycystic Kidney Disease (ADPKD), but can also be isolated. While often asymptomatic, especially when cysts are small, larger or numerous cysts can cause symptoms such as abdominal pain, distension, early satiety, and rarely, complications like cyst infection or rupture. Liver function is usually preserved until very late stages. Management focuses on symptom relief and monitoring.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 25%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms, if they appear, develop gradually over months to years as cysts enlarge.
Duration of Illness (Lifetime)
Chronic, lifelong condition, often progressive.
Cost of Treatment (Initial)
Approximately 500-3000 Euros for initial diagnostic imaging and specialist consultation.
Cost of Treatment (Lifetime)
Highly variable, ranging from 1000-5000 Euros for regular monitoring to potentially 50,000-500,000+ Euros for managing severe complications or liver transplantation in rare cases.
Mortality Rate
Low directly from PLD; increased if severe complications like massive hemorrhage, sepsis from cyst infection, or very rarely liver failure occur. Often influenced by co-existing ADPKD.
Risk of Secondary Damages
Moderate (20-50%) for physical symptoms like chronic pain, abdominal discomfort, and early satiety. Low (<5%) for severe complications like cyst infection, hemorrhage, or significant liver dysfunction. Potential psychological impact from chronic illness.
Probability of Full Recovery
0% (no complete recovery or cure, but symptoms can be managed effectively).
Underlying Disease Risk
High (over 90%) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) in genetic forms of PLD; rare for other underlying conditions.